Maia Biotechnology, Inc. MAIA

MAIA Quotes by TradingView
Institutional shares held 1.39 Million
0 calls
0 puts
Total value of holdings $3.19M
$0 calls
$0 puts
Market Cap $25.2M
10,935,900 Shares Out.
Institutional ownership 12.69%
# of Institutions 21

Quarterly Institutional Activity in MAIA

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding MAIA

View all
View all

Latest Institutional Activity in MAIA

Top Purchases

Q1 2025
Naviter Wealth, LLC Shares Held: 10K ($23K)
10K Shares purchased
New Holding
Q4 2024
Jane Street Group, LLC Shares Held: 39.1K ($89.8K)
39.1K Shares purchased
New Holding
Q4 2024
State Street Corp Shares Held: 53.3K ($122K)
18.9K Shares purchased
54.8% Added
Q4 2024
Vanguard Group Inc Shares Held: 583K ($1.34M)
16.1K Shares purchased
2.85% Added
Q4 2024
Susquehanna International Group, LLP Shares Held: 11.6K ($26.8K)
11.6K Shares purchased
New Holding
View All Buyers

Top Sells

Q4 2024
Halter Ferguson Financial Inc. Shares Held: 241K ($554K)
136K Shares sold
36.07% Reduced
Q4 2024
Jpmorgan Chase & CO Shares Held: 45 ($103)
2 Shares sold
4.26% Reduced
Q2 2024
Morgan Stanley Shares Held: 5.1K ($11.7K)
5K Shares sold
49.53% Reduced
Q2 2024
Wealth Enhancement Advisory Services, LLC Shares Held: 14.8K ($34K)
1.2K Shares sold
7.5% Reduced
Q1 2024
Renaissance Technologies LLC Shares Held: 19K ($43.7K)
92.2K Shares sold
82.91% Reduced
View All Sellers

About MAIA

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

MAIA Chart by TradingView
MAIA Fundamental Data by TradingView

Insider Transactions at MAIA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
Mar 03 2025
Stan Smith Director
BUY
Open market or private purchase
Indirect
25,000 +2.03%
$25,000 $1.5 P/Share
Mar 03 2025
Ramiro Guerrero Director
BUY
Open market or private purchase
Direct
33,333 +5.54%
$33,333 $1.5 P/Share
Feb 24 2025
Stan Smith Director
BUY
Open market or private purchase
Indirect
50,000 +4.06%
$50,000 $1.5 P/Share
Feb 24 2025
Ramiro Guerrero Director
BUY
Open market or private purchase
Direct
73,333 +12.06%
$73,333 $1.5 P/Share
Dec 13 2024
Ramiro Guerrero Director
BUY
Open market or private purchase
Direct
53,418 +9.4%
$53,418 $1.87 P/Share
Dec 13 2024
Stan Smith Director
BUY
Open market or private purchase
Indirect
25,000 +2.16%
$25,000 $1.87 P/Share
Nov 01 2024
Cristian Luput Director
BUY
Open market or private purchase
Direct
22,133 +5.38%
$44,266 $2.51 P/Share
Nov 01 2024
Ramiro Guerrero Director
BUY
Open market or private purchase
Direct
88,534 +17.83%
$177,068 $2.51 P/Share
Nov 01 2024
Steven M Chaouki Director
BUY
Open market or private purchase
Direct
22,133 +16.62%
$44,266 $2.51 P/Share
Nov 01 2024
Stan Smith Director
BUY
Open market or private purchase
Indirect
100,000 +9.46%
$200,000 $2.51 P/Share
Apr 25 2024
Ngar Yee Louie Director
BUY
Open market or private purchase
Direct
19,665 +1.66%
$39,330 $2.03 P/Share
Mar 14 2024
Steven M Chaouki Director
BUY
Open market or private purchase
Direct
34,641 +28.04%
$34,641 $1.17 P/Share
Mar 14 2024
Ngar Yee Louie Director
BUY
Open market or private purchase
Direct
170,940 +12.97%
$170,940 $1.17 P/Share
Mar 14 2024
Stan Smith Director
BUY
Open market or private purchase
Indirect
170,940 +16.62%
$170,940 $1.17 P/Share
Mar 14 2024
Cristian Luput Director
BUY
Open market or private purchase
Direct
69,282 +15.87%
$69,282 $1.17 P/Share
Mar 14 2024
Ramiro Guerrero Director
BUY
Open market or private purchase
Direct
6,928 +2.12%
$6,928 $1.17 P/Share
May 18 2023
Ramiro Guerrero Director
BUY
Open market or private purchase
Direct
1,200 +0.38%
$2,400 $2.47 P/Share
May 15 2023
Cristian Luput Director
BUY
Open market or private purchase
Direct
3,000 +1.0%
$6,000 $2.63 P/Share
Apr 28 2023
Vlad Vitoc Chief Executive Officer
BUY
Open market or private purchase
Direct
4,000 +0.49%
$8,000 $2.5 P/Share
View All Transactions

Last 12 Months Summary

Buy / Acquisition
493K Shares
From 4 Insiders
Open market or private purchase 493K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on MAIA

Follow MAIA Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MAIA shares.

Notify only if
Any

Insider Trading

Get notified when an Maia Biotechnology, Inc. insider buys or sells MAIA shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to MAIA Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MAIA